Monday, 18 Feb 2019

You are here

MPO Antibodies Predict Relapses in MPO-ANCA-Associated Vasculitis

A study of MPO-ANCA positive patients followed serially over 2 years shows that reappearance of MPO‐ANCA may predict  relapse in patients with MPO‐ANCA positive AAV and that routine MPO‐ANCA monitoring is warranted. 

This study aimed to establish a potential link between myeloperoxidase (MPO)‐antineutrophil cytoplasmic antibody (ANCA) and relapse in those with ANCA‐associated vasculitis (AAV). 

It is generally known that PR3-ANCA is generally associated with granulomatosis with polyangiitis (GPA), MPO-ANCA is regarded as a marker for microscopic polyangiitis (MPA)/renal-limited disease. While both are diagnostically important, their predictive value is less certain.  

From two Japanese cohort studies (477 patients),.271 were  MPO‐ANCA positive and met enrollment criteria. Of these, 183 had microscopic polyangiitis, 34 GPA, 15 with eosinophilic granulomatosis with polyangiitis, and 39 were unclassifiable.

In the vast majority, (72%) MPO‐ANCA levels decreased to normal levels within 6 months of treatment. 

Reappearance of MPO‐ANCA was seen in 73 (40%) of 181 patients with complete follow‐up data. Reappearance of MPO‐ANCA was more frequent in thos with a relapse (odds ratio = 26.2 [8.2–101], P < 0.0001) after adjusting for confounding factors.

Routine MPO‐ANCA monitoring should be implemented in patients with MPO AAV and this may be a useful biomarker for predicting relapse.

The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Mortality and Hospitalization with Pulmonary Hypertension in Systemic Sclerosis

PHAROS is a prospective cohort studying the natural history of pulmonary hypertension (PH) in systemic sclerosis (SSc). They have shown that risk factors for poor outcomes in this cohort included male sex, DLCO < 50%, exercise oxygen desaturation, and pericardial effusions. 

Noninfectious Proximal Aortitis Needs Serial Follow-ups

A Cleveland Clinic review of patients undergoing thoracic aortic surgery (1996‐2012) identified 196 patients with histopathology‐proven non‐infectious aortitis. The majority of these patients had a recognized systemic disorder, and serial assessments and imaging is crucial to an accurate diagnosis.

Ten Contemporary Challenges Facing Lupus Treatment

A group of French researchers have pooled their interests to identify the challenges ahead in the management of patients with systemic lupus erythematosus (SLE). 

Elevated Fracture Risk in Lupus

A Medicaid study of lupus (SLE) patients finds that fracture risks are elevated in low‐income SLE and lupus nephritis patients compared to those without SLE.

A cohort study matched Medicaid SLE patients and age‐ and sex‐matched non‐SLE comparators to study the primary outcome of fracture of the pelvis, wrist, hip, or humerus.

Improved Survival with Renal Transplant in SLE

The Annals of Internal Medicine has published a cohort study of lupus nephritis patients with end-stage renal disease showing that renal transplantation is associated with improved survival benefit, and a reduction in death from cardiovascular disease and infection.